Vitamin D receptor-binding site variants affect prostate cancer progression.
Lin VC, Huang SP, Ting HJ, Ma WL, Yu CC, Huang CY, Yin HL, Huang TY, Lee CH, Chang TY, Lu TL, Bao BY.
Lin VC, et al. Among authors: ma wl.
Oncotarget. 2017 May 26;8(43):74119-74128. doi: 10.18632/oncotarget.18271. eCollection 2017 Sep 26.
Oncotarget. 2017.
PMID: 29088772
Free PMC article.